Myelodysplastic Syndrome: Drug Therapy

Therapeutic targets Symptom relief Preservation and improvement of the quality of life Prolongation of survival time Therapy recommendations Therapy of low-risk myelodysplastic syndrome. In the presence of low-grade cytopenia (decrease in cell count) and depending on age and comorbidities (concomitant diseases), it is sufficient to initially observe or wait (“watch and wait”) in these patients. … Myelodysplastic Syndrome: Drug Therapy

Bacterial Meningitis: Causes

Pathogenesis (development of disease) Bacterial meningitis is usually transmitted by droplet infection. Approximately 2.5 cases of the disease occur per 100,000 population annually. Most are infections caused by the bacteria Streptococcus pneumoniae (so-called pneumococci), Neisseria meningitidis (so-called meningococci; a good two-thirds of all cases by serogroup B, about a quarter of all cases by serogroup … Bacterial Meningitis: Causes

Bacterial Meningitis: Therapy

General measures Patients with meningococcal meningitis must be isolated until 25 hours after initiation of therapy. Observance of general hygiene measures! Review of permanent medication due topossible effect on the existing disease. Intensive care monitoring Individuals with bacterial meningitis must be monitored in an intensive care unit to control and, if necessary, immediately regulate all … Bacterial Meningitis: Therapy

Myelodysplastic Syndrome: Prevention

To prevent myelodysplastic syndrome (MDS), attention must be paid to reducing individual risk factors. Environmental exposures – Intoxications (poisonings). Long-term exposure (10-20 years) to toxic (poisonous) substances such as benzenes and also certain solvents – particularly affected are gas station attendants, painters and varnishers, and also airport attendants (kerosene).

Disorders of Consciousness: Somnolence, Sopor and Coma

Disorders of consciousness (synonyms: Drowsiness; Unconsciousness; Clouding of consciousness; Coma; Coma cardiale; Coma cerebrale; Coma hypercapnicum; Coma prolonge; Irritable syndrome of the mesodiencephalon; Coma; Coma-like disorder; Comatose state; Precoma; Drowsiness; Somnolence; Sopor; Stupor; Cerebral coma; ICD-10 R40.-: Somnolence, Sopor and Coma) refer to changes in ordinary everyday or normal consciousness. One can distinguish quantitative from … Disorders of Consciousness: Somnolence, Sopor and Coma

Myelodysplastic Syndrome: Symptoms, Complaints, Signs

The following symptoms and complaints may indicate myelodysplastic syndrome (MDS): Symptoms due to cytopenia (decrease in the number of cells in the blood) (80%). Anemia symptoms (70-80%). Exertional dyspnea (shortness of breath during exertion). Exercise tachycardia (rapid heartbeat under stress). Paleness of the skin and mucous membranes Headache Tiredness and fatigue Dizziness Decreased physical and … Myelodysplastic Syndrome: Symptoms, Complaints, Signs

Polymenorrhea: Diagnostic Tests

Obligatory medical device diagnostics. Vaginal ultrasonography (ultrasound examination using an ultrasound probe inserted into the vagina) – to evaluate the genital organs. Abdominal sonography (ultrasound examination of the abdominal organs) – mainly to assess the kidneys, adrenal glands and ovaries (ovaries). Optional medical device diagnostics -depending on the results of the history, physicalexamination, laboratory diagnostics … Polymenorrhea: Diagnostic Tests

Fatty Liver (Steatosis Hepatis): Or something else? Differential Diagnosis

Congenital malformations, deformities, and chromosomal abnormalities (Q00-Q99). Abetalipoproteinemia (synonym: homozygous familial hypobetalipoproteinemia, ABL/HoFHBL) – genetic disorder with autosomal recessive inheritance; severe form of familial hypobetalipoproteinemia characterized by deficiency of apolipoprotein B48 and B100; defect in the formation of chylomicrons leading to fat digestion disorders in children, resulting in malabsorption (disorder of food absorption). Endocrine, nutritional … Fatty Liver (Steatosis Hepatis): Or something else? Differential Diagnosis